Carlo Contreras
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma (NCT04697576) | Carlo Contreras | 2021-10-20 |
Track Carlo Contreras automatically
Every clearance here is in the API, with alerts when new ones post.